ClinVar Miner

Submissions for variant NM_000314.8(PTEN):c.802-131_935del

dbSNP: rs1860608927
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001219134 SCV001391055 pathogenic PTEN hamartoma tumor syndrome 2019-04-29 criteria provided, single submitter clinical testing This variant is a deletion of the genomic region encompassing part of exon 8 (c.802-132_934del) of the PTEN gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant has been observed in an individual with clinical features of PTEN hamartoma tumor syndrome (Invitae). This variant disrupts the p.Thr277 amino acid residue in PTEN. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 20712882, 23335809, 29706350). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Loss-of-function variants in PTEN are known to be pathogenic (PMID: 9467011, 21194675). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.